Lysine Succinylation Is a Frequently Occurring Modification in Prokaryotes and Eukaryotes and Extensively Overlaps with Acetylation  by Weinert, Brian T. et al.
Cell Reports
ResourceLysine Succinylation Is a Frequently Occurring
Modification in Prokaryotes and Eukaryotes
and Extensively Overlaps with Acetylation
Brian T. Weinert,1 Christian Scho¨lz,1 Sebastian A. Wagner,1 Vytautas Iesmantavicius,1 Dan Su,1 Jeremy A. Daniel,1
and Chunaram Choudhary1,*
1The NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B,
2200 Copenhagen, Denmark
*Correspondence: chuna.choudhary@cpr.ku.dk
http://dx.doi.org/10.1016/j.celrep.2013.07.024
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works
License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source
are credited.SUMMARY
Recent studies have shown that lysines can be post-
translationally modified by various types of acyla-
tions. However, except for acetylation, very little is
known about their scope and cellular distribution.
We mapped thousands of succinylation sites in
bacteria (E. coli), yeast (S. cerevisiae), human
(HeLa) cells, and mouse liver tissue, demonstrating
widespread succinylation in diverse organisms. A
majority of succinylation sites in bacteria, yeast,
and mouse liver were acetylated at the same posi-
tion. Quantitative analysis of succinylation in yeast
showed that succinylation was globally altered by
growth conditions and mutations that affected
succinyl-coenzyme A (succinyl-CoA) metabolism in
the tricarboxylic acid cycle, indicating that suc-
cinylation levels are globally affected by succinyl-
CoA concentration. We preferentially detected
succinylation on abundant proteins, suggesting
that succinylation occurs at a low level and that
many succinylation sites remain unidentified. These
data provide a systems-wide view of succinylation
and its dynamic regulation and show its extensive
overlap with acetylation.INTRODUCTION
Advances in high-resolution mass spectrometry (MS) and anti-
body-based affinity enrichment of acetylated lysine residues
enabled the identification of thousands of acetylation sites
(Choudhary et al., 2009; Kim et al., 2006), triggering a new
appreciation of acetylation as a regulatory posttranslational
modification (PTM). Acetylation, which depends on the meta-
bolic intermediate acetyl-coenzyme A (acetyl-CoA), is reported
to regulate multiple metabolic processes (Guan and Xiong,
2010; Hirschey et al., 2011). Similarly, several other lysine842 Cell Reports 4, 842–851, August 29, 2013 ª2013 The AuthorsPTMs involving short-chain acyl-CoA metabolites are reported,
such as malonylation (Peng et al., 2011; Xie et al., 2012), croto-
nylation (Montellier et al., 2012; Tan et al., 2011), propionylation
(Chen et al., 2007), butyrylation (Chen et al., 2007), and succiny-
lation (Lin et al., 2012). Such acylation could provide an elegant
mechanism to coordinate metabolism and signaling by utilizing
metabolic intermediates as sensors to regulate metabolism
(Wellen and Thompson, 2012). Lysine succinylation was first
shown to occur in the active site of homoserine trans-succiny-
lase (Rosen et al., 2004), although this was assumed to indicate
a reaction intermediate during the transfer of a succinyl group
from succinyl-CoA to homoserine. Docosahexomic acid (DHA)
was shown to promote the succinylation of lysine residues
(Kawai et al., 2006), suggesting possible implications of DHA
exposure in the CNS. Zhang et al. (2011) utilized an antibody-
based enrichment strategy and MS-based proteomics to
identify several dozens of succinylation sites in bacteria. Subse-
quent work identified several succinylation sites in animal
tissues (Du et al., 2011) and on histones (Xie et al., 2012). DHA
was implicated in the formation of succinylated lysines (Kawai
et al., 2006), and sodium succinate was shown to promote
succinylation in E. coli (Zhang et al., 2011). However, the mech-
anism of succinylation and the succinyl donor to lysine remains
unknown, and a global analysis of lysine succinylation in diverse
organisms is lacking.
Here, we developed a method based on antibody-based
affinity enrichment of succinylated peptides followed by
strong cation exchange (SCX) chromatography to identify
thousands of lysine succinylation sites in bacteria (E. coli),
budding yeast (S. cerevisiae), human cervical cancer (HeLa)
cells, and mouse liver tissue. To obtain more detailed insights
into succinylation, we used a quantitative MS approach to
characterize succinylation in yeast strains deficient for the
formation of succinyl-CoA or for its subsequent conversion to
succinate. A comparative bioinformatic analysis of succinylation
in these four organisms revealed several features of succinyla-
tion as a PTM and the biases inherent in the analysis of succiny-
lation by MS. The data set, including all identified succinylation
sites and their quantification, is provided in the Supplemental
Information as a resource to the research community.
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Figure 1. Enrichment of Succinylated Peptides from E. coli Lysate
(A) Experimental approach used to identify succinylated (S) peptides.
(B) Succinylated peptides are further enriched by low pH elution from a
micro-SCX column. The column chart shows the fraction of succinylated
peptides present in each elution fraction.
(C) Micro-SCX efficiently separates succinylated peptides. The pie chart
shows the number of fractions in which any given succinylated peptide was
identified.
See also Figure S1.RESULTS
Enrichment of Succinylated Peptides and Identification
by MS
In order to map lysine succinylation sites in vivo, proteins were
isolated fromexponentially growing cells or, in the case ofmouse
liver tissue, from 16-week-old animals. Proteins were digested
with endoprotease Lys-C and trypsin to yield tryptic peptides,
and succinylated peptides were enriched using succinyllysine
polyclonal antibody. The enrichment of succinylated peptides
with succinyllysine antibody, and the verification of lysine succi-
nylation by orthogonal methods, were validated in a previous
study (Zhang et al., 2011). Peptides were further separated by
microscale SCX chromatography. SCX microcolumns were
prepared by packing a micropipette tip with Empore (3M) disks
containing cation exchange beads immobilized in a Teflonmesh-
work, as described previously (Rappsilber et al., 2007). We
further modified this protocol by using pH-based elution, previ-
ously described for use in strong anion exchange fractionation
(Wisniewski et al., 2009), and by including a high percentage of
acetonitrile in the buffer system (for details, see Experimental
Procedures). This method is particularly suited for the fraction-
ation of posttranslationally modified peptides following antibody
affinity enrichment. Peptides eluted from antibody beads with
acidifiedwater can be directly loaded onto the SCXmicrocolumn
and eluted with a step-wise pH gradient. Fractionation can be
performedwith asmany individual fractions as desired, providing
flexibility in reducing sample complexity. The presence of a high
concentration of acetonitrile in the buffer system helps to remove
hydrophobic contaminants, such as detergents, and prevents
loss of peptides through hydrophobic interactions. In addition,
the procedure is rapid and the small scale and simplicity of thesystem reduces sample handling. Following peptide separation
into three fractions, the sampleswere analyzed by liquid chroma-
tography-tandem mass spectrometry (LC-MS/MS) and peptide
sequences were identified with a maximum false discovery rate
of 1% using MaxQuant (Cox et al., 2011) (Figure 1A).
Widespread Lysine Succinylation in E. coli
In order to optimize our proteomics workflow and to obtain a
detailed view of succinylation, we performed succinyllysine
enrichment from E. coli. Fractionation of affinity-enriched pep-
tides by micro-SCX resulted in further enrichment of succiny-
lated peptides at low pH elutions (Figure 1B). Succinylation of
lysine neutralizes its positive charge and introduces a negative
charge. For this reason, the SCX-based chromatography is high-
ly suited for the selective enrichment of succinylated peptides,
which helps to further increase the relative abundance and
detection of these peptides byMS. Fractionation of succinylated
peptides by micro-SCX was efficient, with 77% of peptides
occurring in only one fraction and 95% of peptides occurring in
one or two fractions (Figure 1C). We identified 2,572 lysine suc-
cinylation sites occurring on 990 proteins (Table S1). Succinyla-
tion occurred on diverse proteins involved in nearly all aspects of
cellular functions (Figure S1A), indicating that succinylation is a
widespread and frequently occurring PTM in bacteria. We found
succinylation on all 14 proteins that were previously shown to be
succinylated (Zhang et al., 2011), including 72% (50/69) of the
previously identified sites (Table S1). Furthermore, we found an
additional 89 succinylation sites on these 14 proteins, indicating
extensive modification of these proteins by succinylation and
demonstrating improved sensitivity of our method for global
succinylation analysis.
The mitochondrial sirtuin SIRT5 has an atypical acyl-binding
domain that allows this enzyme to catalyze the desuccinylation
of lysine residues (Du et al., 2011). The only known sirtuin in
E. coli, CobB, has a similar sequence in the conserved acyl-
binding domain, suggesting that CobB may be able to catalyze
desuccinylation of lysines (Du et al., 2011). To test this, we
used stable isotope labeling with amino acids in cell culture
(SILAC) (Ong et al., 2002) to quantify relative differences in
succinylation between wild-type and isogenic cobBmutant cells
(cobBD). We quantified succinylation at more than 2,000 sites
(Table S2) and found that succinylation was not globally altered
by loss of CobB (Figure S1B). We expected that loss of a desuc-
cinylase activity would result in an increased abundance of lysine
succinylation. However, the distribution of succinylation site
ratios that were corrected for differences in protein abundance
between wild-type and cobBD cells was centered on a median
value of 0.90, demonstrating that succinylation was not globally
elevated in themutant cells. In contrast, we recently showed that
loss of cobB caused increased acetylation at hundreds of sites
(Weinert et al., 2013). Based on these results, we conclude that
CobB does not regulate succinylation levels globally, although
there may exist sites that are regulated in a site-specific manner
but not detected in our analysis.
Succinylation in Eukaryotes
To understand the scope of succinylation in eukaryotes, we used
the above-described approach to identify lysine succinylationCell Reports 4, 842–851, August 29, 2013 ª2013 The Authors 843
Table 1. Succinylation Sites Identified in This Study Compared
with Previous Studies
Species
Identified in This
Study Previously Known
Sites Proteins Sites Proteins Reference
E. coli 2,572 990 69 14 Zhang et al., 2011
S. cerevisiae 1,345 474 7 4 Xie et al., 2012
H. sapiens
(HeLa)
2,004 738 13 4 Du et al., 2011
M. musculus
(liver)
2,140 750 7 3 Du et al., 2011sites in budding yeast (S. cerevisiae), human cervical cancer
(HeLa) cells, and mouse liver tissue (Tables S3, S4, and S5). As
in E. coli, fractionation by micro-SCX resulted in further enrich-
ment of succinylated peptides in low pH fractions in all samples
analyzed (Figure S2A). We found 1,345 sites in yeast, 2,004 sites
in HeLa cells, and 2,140 sites in mouse liver (Table 1), greatly
expanding the number of known succinylation sites in these
organisms. We examined the amino acid sequences flanking
succinylation sites in order to determine if particular amino acids
were biased to occur adjacent to succinylated lysines. Filled logo
motifs were generated for succinylation sites in all four organ-
isms tested (Figure S2B). The sequence logos do not reveal a
strong bias for a particular amino acid; however, aspartic acid,
glutamic acid, and lysine occurred most frequently at the +1 po-
sition, while leucine and alanine occurred frequently at the 1
position. These biases may reflect a genuine preference for
these amino acids or may result from the sequence bias of
antibodies that were used to selectively enrich succinylated pep-
tides, as was previously seen for acetyllysine enrichment (Hen-
riksen et al., 2012). In order to determine whether succinylation
was biased to occur within particular secondary structural
domains on proteins, we used the secondary structure assign-
ments from the UniProt database, when present, to compare
succinylated and nonsuccinylated lysines. We found amoderate
bias for succinylation to occur in helical regions and a moderate
bias against coiled regions in all four organisms (Figure S2D).
Subcellular Distribution of Succinylated Proteins
Succinyl-CoA and succinate are primarily formed in the
mitochondria during the tricarboxylic acid (TCA) cycle or via
odd-numbered fatty acid oxidation. However, succinate can
traverse the mitochondrial membrane and can be formed in
the cytoplasm as a side product from a-ketoglutarate-depen-
dent enzymes (Hausinger, 2004). Although acetyl-CoA exists in
separate mitochondrial and nonmitochondrial pools (Takahashi
et al., 2006; Wellen et al., 2009), the subcellular distribution
and compartmentalization of succinyl-CoA, to our knowledge,
is not known. Using localization data from GFP-tagged proteins
(Huh et al., 2003) we found that only 8% of succinylation sites
occurred on mitochondrial proteins in yeast (Figure 2A). In order
to localize human and mouse proteins to different subcellular
compartments, we analyzed the association of succinylated pro-
teins with the UniProt keywords ‘‘mitochondrion,’’ ‘‘cytoplasm,’’
and ‘‘nucleus.’’ Only proteins that could be associated with a844 Cell Reports 4, 842–851, August 29, 2013 ª2013 The Authorskeyword were analyzed. In HeLa cells and mouse liver, the pro-
portion of succinylation occurring on mitochondrial proteins was
significantly larger than in yeast, with the greatest proportion
found in mouse liver, possibly due to the abundance of mito-
chondria in this tissue (Figure 2B). This finding was verified by
examining proteins designated asmitochondrial in theMitoCarta
(Pagliarini et al., 2008) database (Figure S3A). The occurrence of
frequent lysine succinylation outside of mitochondria suggests
that succinyl-CoA, succinate, or another succinyl-metabolite
drives succinylation in the cytoplasm and nucleus.
Our analysis indicated a significant difference in the subcellu-
lar distribution of lysine succinylation between yeast and
mammals (Figures 2A and 2B). However, the detection of succi-
nylation sites is biased to occur on more abundant proteins (see
below), which are more readily detected in the MS. Since mito-
chondrial proteins are more abundant in HeLa cells and mouse
liver, a greater proportion of succinylation sites are identified
on these proteins. When accounting for these differences in pro-
tein abundance, succinylation is similarly biased to occur on
mitochondrial proteins in all three eukaryotic organisms exam-
ined (Figure S3B). Thus, differences in the abundance of mito-
chondria between these samples likely account for the greater
proportion of succinylation sites found onmitochondrial proteins
in HeLa cells and mouse liver.
Overlap between Lysine Succinylation and Acetylation
Lysine residues can bemodified by a plethora of PTMs, including
ubiquitylation, sumoylation, methylation, biotinylation, acetyla-
tion, and other forms of acylation. Of these modifications, acet-
ylation has been extensively mapped in diverse organisms. We
compared the succinylation sites identified in our study to previ-
ously determined acetylation sites in E. coli (Weinert et al., 2013)
and S. cerevisiae (Henriksen et al., 2012) and to acetylation sites
that we identified in the sameHeLa cells and inmouse liver tissue
used in this study (Tables S6 and S7). We found that 66% of
E. coli, 56% of yeast, 27% of human, and 57% of mouse succi-
nylation sites were acetylated at the same position (Figure 2C;
Tables S3, S4, and S5). The small overlap found in HeLa cells
likely occurs because succinylation was detected 2-fold
more often onmitochondrial proteins than acetylation sites, while
in mouse liver succinylation was detected only 1.3-fold more
often on mitochondrial proteins, and a similar fraction of yeast
succinylation and acetylation occurred onmitochondrial proteins
(Figure 2D). Thus, the greater overlap between acetylation and
succinylation in yeast and mouse liver is likely due to the more
similar subcellular distribution of these modifications in these
two samples. In HeLa cells andmouse liver tissue, the proportion
of acetylation occurring on mitochondrial proteins is significantly
lower than the proportion of succinylation occurring on mito-
chondrial proteins (Figure 2D). In contrast, a similar proportion
of yeast acetylation and succinylation occurs on mitochondrial
proteins. These observations show that acetylation and succiny-
lation occur frequently at the same sites; however, the subcellu-
lar distribution of these modifications is different in mammals
compared to yeast. This likely reflects the mitochondrial origin
of succinyl-CoA, which drives succinylation (shown below), while
acetyl-CoA exists in distinct mitochondrial and nonmitochondrial
pools (Takahashi et al., 2006; Wellen et al., 2009).
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Figure 2. Subcellular Distribution of Lysine
Succinylation Sites and Their Overlap with
Acetylation
(A) The Venn diagrams show the subcellular
distribution of succinylation sites determined in
S. cerevisiae using their previously published
subcellular localizations (Huh et al., 2003) and by
associating H. sapiens and M. musculus proteins
with the UniProt keywords ‘‘mitochondrion,’’
‘‘cytoplasm,’’ and ‘‘nucleus.’’
(B) The fraction of mitochondrial succinylation
is significantly higher in human cells and in
mouse liver. The column graph shows the fraction
of sites occurring on mitochondrial proteins in
S. cerevisiae (Sc), H. sapiens (Hs), and
M. musculus (Mm). Statistical significance was
determined by Fisher exact test (*p < 1 3 1020).
(C) The Venn diagrams show the overlap between
succinylation and acetylation sites. The fraction of
succinylation sites that were also acetylated is
indicated in parenthesis.
(D) The subcellular distribution of acetylation and
succinylation differs in mammals. The fraction of
succinylation or acetylation occurring on mito-
chondrial proteins was determined as in (A).
Statistical significance was determined by Fisher
exact test (*p < 1 3 1020). N.S., not significant.
See also Figures S2 and S3.Succinylation Depends on Succinyl-CoA Formed in
Mitochondria
In order to identify the succinyl donor to lysine throughout the
cell, we used a SILAC-based quantitative approach to determine
whether enzymes that metabolize succinyl-CoA and succinate
during the TCA cycle affect lysine succinylation. In yeast,
a-ketoglutarate is converted to succinyl-CoA by the mitochon-
drial a-ketoglutarate dehydrogenase complex, composed of
Kgd1, Kgd2, and Lpd1. Kgd1 is required for a-ketoglutarate
dehydrogenase activity and is under control of catabolite repres-
sion, whereby growth on galactose-containing media induces
kgd1 gene expression (Repetto and Tzagoloff, 1989). Succinyl-
CoA is further converted to succinate by succinyl-CoA ligase,
composed of Lsc1 and Lsc2. Lsc1 is required for succinyl-CoA
ligase activity and, similar to Kgd1, is induced by growth on
galactose-containing media (Przybyla-Zawislak et al., 1998).
We designed an experimental approach to test whether lysine
succinylation was affected by growth on galactose-containing
media and whether loss of kgd1 or lsc1 further affected lysine
succinylation (Figures 3A and 3B). In both experiments, growth
on galactose caused a 1.7-fold increase in global lysine succi-
nylation while mitochondrial proteins were more robustly
affected with a 2.7- to 4.7-fold increase in succinylation (Fig-
ure 3C; Table S8). Loss of kgd1 caused a highly significant
4-fold reduction in global succinylation levels (relative to
wild-type cells grown on galactose) and a 6-fold reduction in
mitochondrial succinylation. In contrast, loss of lsc1 caused a
significant 3-fold increase in succinylation of all proteins and
of mitochondrial proteins. It is striking that the entire distribution
of SILAC ratios was altered, indicating that nearly all detectable
succinylation sites were affected by these manipulations.
Growth on galactose, which is known to induce the enzymesthat catalyze the formation of succinyl-CoA in the TCA cycle,
caused increased succinylation, suggesting that this increase
occurred due to increased concentration of succinyl-CoA in
cells. Similarly, loss of lsc1 blocks the conversion of succinyl-
CoA to succinate and would likely cause accumulation of
succinyl-CoA. We found increased succinylation in lsc1D cells,
further suggesting that succinylation depends on succinyl-CoA
concentration. Although we have not assayed succinyl-CoA
concentration in this work, loss of kgd1 causes reduced
succinate levels in yeast (Arikawa et al., 1999). Since succinate
is downstream of succinyl-CoA in the TCA cycle, kgd1D cells
should have reduced levels of succinyl-CoA as well. Importantly,
our data show that succinyl-CoA formed through this pathway
affects succinylation levels throughout the cell, indicating that
succinyl-CoA is the succinyl donor to lysine and that succinyl-
CoA may traverse the mitochondrial membrane or be generated
outside of mitochondria.
Succinylation Abundance
In order to determine the relationship between protein abun-
dance and succinylation in our samples, we determined relative
protein abundances using an intensity-based absolute quantifi-
cation (iBAQ) method (Schwanha¨usser et al., 2011). This method
provides a good estimate of relative protein abundances for
these samples since protein abundance is determined using
the same samples from which succinylated peptides were
enriched, thus controlling for differences introduced during
sample preparation. We found succinylation more frequently
on abundant proteins (Figure 4A), suggesting that, given
adequate depth of coverage, we would detect succinylation on
most proteins. This bias suggests that succinylation occurs at
a low stoichiometry, as we aremore likely to detect succinylationCell Reports 4, 842–851, August 29, 2013 ª2013 The Authors 845
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Figure 3. Lysine Succinylation Depends on Succinyl-CoA Formed
through the Tricarboxylic Acid Cycle
(A) Schematic overview of the conversion of a-ketoglutarate to succinate
during the tricarboxylic acid (TCA) cycle. Enzymes investigated in this study
are shown in red type.
(B) Diagram indicating the quantitative mass spectrometry approach using
stable isotope labeling with amino acids in cell culture (SILAC). The genotype
(wild-type [WT]) and growth condition (glucose [Glu.] or galactose [Gal.]) are
indicated for each of the SILAC labeling conditions in each experiment.
(C) The generation of succinyl-CoA affects lysine succinylation. Box plots
show the distributions of SILAC ratios for succinylation sites. The box indicates
the middle 50% of the distribution, inner hatch marks indicate 82%, and outer
hatch marks 94% of the distribution; the median is indicated by the black line
and the average by the red line. Significant differences between distributions
were calculated by Wilcoxon test.
See also Figure S5.if proteins are more abundant. Consistent with this idea, the
frequency of observed succinylation (number of sites per 100
amino acids) is correlated with protein abundance in all four
organisms (Figure 4B). This comparison indicates that we detect
more succinylation sites on abundant proteins, suggesting that
succinylation may target most of the accessible lysine residues
in cells and that protein abundance is the determining factor in
its detection. This correlation is notable considering that the
lysine content, and accessibility of these lysines, is likely to
vary between proteins. In contrast, the frequency of observed
phosphorylation is poorly correlated with protein abundance in
yeast, HeLa cells, andmouse liver (Figure S4).While we detected
many succinylation sites on highly abundant proteins, we did not
detect succinylated peptides without antibody enrichment, even
though we readily detect peptides from proteins that are more
than two orders of magnitude less abundant (Figure 4A).846 Cell Reports 4, 842–851, August 29, 2013 ª2013 The AuthorsTogether, these observations suggest that most succinylation
occurs at a low stoichiometry.
Phosphoglycerate kinase (Pgk1) is one of the most abundant
proteins in yeast according to Ghaemmaghami et al. (2003)
and the iBAQ method used in this study. When we enriched for
succinylated peptides from yeast lysate, we identified 17 succi-
nylation sites on Pgk1 (Table S3). However, when we analyzed
purified, GFP-tagged Pgk1, we identified only a single succiny-
lated peptide from this protein, even though we identified
unmodified peptides covering 95%of the protein sequence (Fig-
ure 4C). If we then enriched for succinylated peptides from the
same protein preparation, we identified 14 succinylated
peptides from Pgk1 and five succinylated peptides from GFP
(Figure 4C; Table S9). Nonsuccinylated peptides from Pgk1
andGFPweremedian100-foldmore intense than succinylated
peptides from these proteins, even though the succinylated
peptides had been enriched by 100-fold before MS analysis
(Figure 4D), indicating that succinylation occurred at a very low
level. Succinylation of GFP suggests that a foreign protein can
be targeted by succinylation, and the similar median succiny-
lated peptide intensities from Pgk1 and GFP suggest that succi-
nylation occurs to a similar degree on both proteins.
Nonenzymatic Succinylation
A low level of succinylation, together with the global succinyla-
tion dynamics in yeast grown on galactose, in kgd1D cells and
in lsc1D cells, suggested that succinylation may occur by a
nonenzymatic mechanism dependent on succinyl-CoA concen-
tration. A previous study showed that acetyl-CoA can nonenzy-
matically acetylate lysines in vitro (Paik et al., 1970). In order to
test whether succinyl-CoA can nonenzymatically succinylate
proteins, we mixed increasing concentrations of succinyl-CoA
with BSA and eggwhite albumin (ovalbumin). Increased succiny-
lation relative to untreated control samples was assayed by MS
using TMT isobaric mass tags for peptide quantification. We
found that succinyl-CoA caused increased succinylation in a
concentration-dependent manner at all identified succinylation
sites (Figure S5). Although we cannot completely rule out the
presence of a succinyl-transferase activity in these reactions, it
is likely that succinylation occurred by direct chemical modifica-
tion of lysine residues as BSA and ovalbumin were isolated from
two different extracellular sources yet both showed a similar
reactivity to succinyl-CoA. Our reactions were performed at or
below physiological pH, suggesting that nonenzymatic succiny-
lation may occur by exposure to succinyl-CoA in cells. However,
it is impossible to rule out the potential existence of enzymatic
succinyl-transferase activities in cells and their contribution to
lysine succinylation in vivo.
Succinylation of Metabolic Proteins in Mouse Liver
Mitochondrial proteins were highly succinylated in mouse liver.
As much as 70% of succinylation sites occurred on mitochon-
drial proteins, and mitochondrial proteins were more frequently
multiply succinylated than nonmitochondrial proteins (Fig-
ure S6A). A total of 32% (348/1,097) of the proteins designated
as mitochondrial in the MitoCarta database (Pagliarini et al.,
2008) were succinylated. We performed Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway enrichment analysis
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Figure 4. Protein Abundance Is a Determining Factor in the Detection of Succinylation Sites
(A) Detection of succinylation is biased to occur on abundant proteins. The histograms show experimentally determined relative protein abundance distributions
for the samples used to analyze succinylation in this study.
(B) The frequency of detected succinylation sites is correlatedwith protein abundance. The scatterplots show the relationship between protein abundance (Log10
iBAQ) and succinylation frequency (number of sites per 100 amino acids). The number (n) of proteins analyzed and the Spearman’s correlation coefficient (r) is
shown.
(C) The diagram illustrates the analysis of purified Pgk1-GFP by mass spectrometry (MS).
(D) Succinylated peptides are significantly less intense. The box plots compare peptide intensity distributions for the indicated classes of peptides shown in (C).
Nonsuccinylated peptide intensities from both Pgk1 and GFP were determined without enrichment. Succinylated peptide intensities were determined after
100-fold enrichment of succinylated peptides, as shown in (C). The number of peptides examined is shown in parentheses. Significance (p value) was
determined by Wilcoxon test comparing succinylated peptide intensities to nonsuccinylated peptide intensities.
See also Figures S4, S5, and Table S9.and found that many metabolic pathways were significantly en-
richedwithin the group of succinylated proteins (Figure S6B). We
further illustrated the occurrence of succinylation and acetylation
in three key metabolic pathways: the TCA, the urea cycle, and
fatty acid oxidation (Figure 5). Nearly every enzyme in the TCAcycle and in the urea cycle was succinylated and the majority
of sites were also found to be acetylated. These results mirror
the observation of widespread acetylation of metabolic proteins
from human liver tissue (Zhao et al., 2010), suggesting that both
of these acylations may play a role in regulating metabolicCell Reports 4, 842–851, August 29, 2013 ª2013 The Authors 847
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Figure 5. Succinylation of Enzymes
Involved in the Tricarboxylic Acid Cycle,
the Urea Cycle, and Fatty Acid Oxidation
Succinylated enzymes identified in mouse liver
tissue are shown in green ovals, sites that were
found to be both acetylated and succinylated
are shown as blue circles, sites only found to
be succinylated are shown as red circles. The
enzymes shown are pyruvate dehydrogenase E1
component subunit alpha (PDHA1), citrate
synthase (CS), aconitate hydratase (ACO2),
isocitrate dehydrogenase (IDH2), dihydro-
lipoamide S-succinyltransferase (DLST), succinyl-
CoA ligases G1, G2, and A1 (SUCLG1, SUCLG2,
and SUCLA1), succinate dehydrogenase (SDHA),
fumarate hydratase (FH), malate dehydrogenase 1
and 2 (MDH1 and MDH2), glutamate dehydroge-
nase (GLUD1), carbamoyl phosphate synthetase I
(CPS1), ornithine transcarbamoylase (OTC), argi-
ninosuccinate synthetase (ASS), argininosucci-
nate lyase (ASL), arginase 1 (ARG1), short-,
medium-, long-, and very-long-chain-specific
acyl-CoA dehydrogenases (ACADS, ACADM,
ACADL, and ACADVL), enoyl-CoA delta isom-
erase 1 (ECI1), peroxisomal trans-2-enoyl-CoA
reductase (PECR), enoyl-CoA hydratase/3,2-
trans-enoyl-CoA isomerase,3-hydroxyacyl-CoA
dehydrogenase (EHHADH), long-chain enoyl-CoA
hydratase, long-chain 3-hydroxyacyl-CoA dehy-
drogenase alpha and beta (HADHA and HADHB),
and nonspecific lipid-transfer protein (SCP).processes. However, as noted above, the preponderance of
lysine succinylation on mitochondrial proteins and metabolic
pathways in mouse liver is most likely due to a technical bias
to detect succinylation sites on the most abundant proteins,
which are predominantly mitochondrial in mouse liver.
Carbamoyl phosphate synthase 1 (CPS1) has reduced
activity in SIRT5 mice (Nakagawa et al., 2009), and one of three
previously identified succinylation sites was affected by loss of
SIRT5 (Du et al., 2011). In mouse liver we found the greatest
number of succinylation sites on CPS1 (44 sites), including all
three previously known sites. CPS1 was acetylated at 52 sites,
39 of which were also succinylated. These results are not sur-
prising, since we determined that CPS1 was the fifth most
abundant protein in our liver samples and it is also relatively
large, containing 1,500 amino acids. CPS1 plays an important
role in initiating the urea cycle by catalyzing the synthesis of
carbamoyl phosphate from ammonia and bicarbonate. We
found that every enzyme present in the urea cycle is succiny-
lated in mouse liver tissue (Figure 5). Previous studies showed
that ornithine transcarboxylase (OTC), another urea cycle
enzyme, is regulated by acetylation at lysine 88 (Yu et al.,
2009) and that the mitochondrial deacetylase SIRT3 regulates
acetylation at this site in response to calorie restriction (Hallows
et al., 2011). We found that OTC is succinylated at lysine 88 in
mouse liver, indicating that this critical lysine residue is targeted
by both succinylation and acetylation. Glutamate dehydroge-
nase (GLUD1) was one of the most highly succinylated proteins
with 15 sites. GLUD1 catalyzes the oxidative deamination of848 Cell Reports 4, 842–851, August 29, 2013 ª2013 The Authorsglutamate to a-ketoglutarate and ammonia, thereby providing
a source of ammonia to enter the urea cycle via CPS1.
GLUD1 was previously shown to be regulated by SIRT4-depen-
dent ADP-ribosylation in pancreatic b cells (Haigis et al., 2006).
The observation that SIRT3, SIRT4, and SIRT5 have roles in
regulating OTC, GLUD1, and CPS1, respectively, raises the
interesting possibility that multiple PTMs and mitochondrial
sirtuins regulate the urea cycle. Our data suggest that succiny-
lation may play a role in affecting the activity of these proteins
and regulating the urea cycle, as was previously suggested
for CPS1 (Du et al., 2011).
We found a striking overlap between acetylated and succiny-
lated lysines overall (Figure 2C) and in mitochondrial metabolic
pathways specifically (Figure 5). We found that succinylation
occurred at many sites that were previously shown to be regu-
lated by acetylation, including homologous lysines 172, 344,
and 579 on 3,2-trans-enoyl-CoA isomerase,3-hydroxyacyl-CoA
dehydrogenase (EHHADH) and malate dehydrogenase 2
(MDH2) lysines 185, 301, 307, and 314 (Zhao et al., 2010); malate
dehydrogenase 1 (MDH1) lysines 118 and 298 (Kim et al., 2012),
long-chain-specific acyl-CoA dehydrogenase (ACADL) lysine 42
(Hirschey et al., 2010); and super oxide dismutase (SOD2) lysines
68, 122, and 130 (Chen et al., 2011; Tao et al., 2010). The occur-
rence of succinylation at these positions raises the possibility of
these enzymes being affected by both modifications and
furthermore complicates the functional analysis of either modifi-
cation by mutation, which would abrogate both acetylation and
succinylation, as well as other possible lysine modifications.
DISCUSSION
In this study, we provide a detailed view of the scope of lysine
succinylation in four different, evolutionarily diverse organisms.
The identification of more than 2,500 succinylation sites in
E. coli is striking because, in contrast to canonical regulatory
PTMs, such as phosphorylation, the complexity of succinylation
appears to be greater in bacteria than in eukaryotes. Our results
indicate that during the evolution from bacteria to eukaryotes,
the relative (in terms of proteome complexity) frequency of
succinylation appears to have decreased. In eukaryotic cells,
the frequency of succinylation in bacterially derived mito-
chondria is greatest. This is in stark contrast to protein phos-
phorylation (Weinert et al., 2011) and points to an interesting
similarity between succinylation and acetylation in bacteria
and mitochondria.
In yeast cells, succinylation depended on succinyl-CoA
formed through the TCA cycle, indicating that succinyl-CoA is
the succinyl donor to lysine and that succinyl-CoA concentra-
tion affects succinylation levels globally. Our data suggested
that most lysine succinylation occurs at low levels, and a
technical bias to detect succinylation on abundant proteins
suggested that succinylation likely occurs at many more sites
than were identified in this study. These observations sug-
gested that succinylation may occur nonenzymatically, and
we showed that succinyl-CoA could succinylate lysine residues
on purified proteins in vitro, suggesting that nonenzymatic
succinylation by succinyl-CoA may occur frequently in cells.
These data are interesting as a lysine succinyltransferase has
not been identified and the mechanism of lysine succinylation
remains unknown. Previous studies have shown that changes
in acetyl-CoA levels can affect lysine acetylation (Takahashi
et al., 2006; Wellen et al., 2009) as well as protein N-terminal
acetylation (Yi et al., 2011). Some acetyltransferases have an
affinity for acetyl-CoA that is similar to physiological acetyl-
CoA concentrations, suggesting that fluctuations in acetyl-
CoA levels may regulate acetylation (Cai et al., 2011). A similar
mechanism may regulate enzyme-catalyzed succinylation in
cells and would be consistent with our observations. Further-
more, site-specific, enzyme-catalyzed succinylation may occur
in parallel with nonenzymatic succinylation, complicating the
functional categorization of sites identified by MS. Our results
in yeast showed that succinylation occurred at a low level
and was globally affected by succinyl-CoA metabolism,
suggesting a common, possibly nonenzymatic mechanism of
modification. However, yeast appears to lack a lysine desucci-
nylase and the mechanisms and regulation of succinylation in
organisms that contain the regulatory desuccinylase SIRT5
may be more complex.
Our results show extensive overlap between succinylation and
acetylation, raising the possibility of crosstalk between these
PTMs. However, it remains to be determined whether different
acylations have unique regulatory roles or if they perform redun-
dant functions. Also, it would be interesting for future studies to
investigate the relative stoichiometries of various acylations
occurring on the same lysines. We provided a glance of succiny-
lation in evolutionarily diverse organisms, and these data provide
insights into succinyl-CoA metabolism and succinylation.EXPERIMENTAL PROCEDURES
Cell Culture and Lysate Preparation
Details concerning the origin of cells and tissues and the preparation of protein
lysates for MS analysis can be found in the Extended Experimental
Procedures. All mouse work was performed according to national and interna-
tional guidelines approved by the Danish Animal Ethical Committee and the
review board at the Faculty of Health and Medical Sciences, University of
Copenhagen.
Succinyllysine Enrichment and SCX-Based Peptide Fractionation
Peptides were mixed with 200 ml succinyllysine polyclonal rabbit antibody
(PTM Biolabs) and 50 ml of rec-Protein G Sepharose (Invitrogen) or with
100 ml of preconjugated succinyllysine antibody resin (PTM Biolabs). Reac-
tions were incubated overnight at 4C on a rotating wheel. The immunoprecip-
itates were washed three times at 4C with IP-A buffer (50 mMMOPS [pH 7.2]
and 50 mM NaCl) and once with H2O. Immuno-enriched peptides were eluted
with 3 3 100 ml acidified H2O (0.2% trifluoroacetic acid [TFA]) and loaded
directly onto a strong cation exchange (SCX) microtip column prepared as
described (Rappsilber et al., 2007; Wisniewski et al., 2009). The SCX microtip
was conditioned with 100 ml 0.1% TFA, 50% acetonitrile, 100 ml pH 8.5 elution
buffer (see below), and 100 ml 0.1% TFA, 50% acetonitrile. After loading, the
column was washed with an additional 100 ml 0.1% TFA, 50% acetonitrile
and peptides were eluted by stepwise 100 ml aliquots of elution buffer
(20 mM acetic acid, 20 mM boric acid, 20 mM phosphoric acid, 40%
acetonitrile) at pH 4.5, pH 5.5, and pH 8.5 or pH 11. Peptide eluateswere briefly
evaporated to remove acetonitrile and then loaded onto C18 stage-tips as
described previously (Rappsilber et al., 2007).
SILAC Labeling of E. coli and Yeast
Wild-type BW25113 and isogenic mutant cobBD (JW1106) strains (Baba et al.,
2006) were obtained from the E. coli Genetic Resource Center (http://cgsc.
biology.yale.edu). For SILAC labeling, cells were grown in M9 minimal media
supplemented 0.2% glucose and with 100 mg/ml lysine (SILAC ‘‘light’’) or
13C6
15N2-lysine (Cambridge Isotope Laboratories) (SILAC ‘‘heavy’’). Wild-
type S. cerevisiae cells (BY4742, MATalpha his3D1 leu2D0 lys2D0 ura3D0;
Open Biosystems), lsc1D (BY4742, lsc1::KanMX; Open Biosystems), and
kgd1D (BY4742, kgd1::KanMX; Open Biosystems) were cultured in synthetic
complete media (US Biologicals) supplemented with lysine (SILAC ‘‘light’’),
2H4 -lysine (SILAC ‘‘medium’’), or
13C6
15N2-lysine (SILAC ‘‘heavy’’). Cells
were harvested during the midexponential phase of growth and lysate was
prepared and succinylated peptides were enriched as described above.
Nonenzymatic Succinylation and Labeling with TMT Isobaric Mass
Tags
BSA (Sigma) and eggwhite albumin (ovalbumin) (Sigma) were prepared in PBS
(pH 7.2) at 10 mg/ml. A total of 1 mg protein (0.1 ml) was mixed with 1/10 vol of
freshly prepared succinyl-CoA in H2O to yield the final concentrations shown in
Figure 5. Reactions were incubated at 30C for 3 hr and stopped by addition of
5 vol20C acetone, which precipitated the protein. Protein precipitates were
resuspended in 0.2 ml 100 mM triethyl ammonium bicarbonate (TEAB) and
digested for 16 hr by addition of 1/100 (w/w) trypsin protease (Sigma). Labeling
with TMTsixplex isobaric mass tags (Thermo Scientific) was performed
according to the manufacturer’s instructions. Quantification of TMT mass
tags may be inaccurate if additional peptides are coisolated with the targeted
peptide ion (Ting et al., 2011). In order to avoid this effect, we restricted the
quantification of TMT mass tags to MS/MS scans in which the targeted parent
ion constituted a minimum of 90% of the total ion current.
MS, Peptide Identification, and Computational Analysis
Peptide fractions were analyzed by online nanoflow LC-MS/MS using a
Proxeon easy nLC system (Thermo Scientific) connected to a Q-Exactive
(Thermo Scientific) mass spectrometer. The Q-Exactive was operated using
Xcalibur 2.2 in the data-dependent mode to automatically switch between
MS and MS/MS acquisition as described elsewhere (Kelstrup et al., 2012;
Michalski et al., 2011). Peptides were fragmented using higher energy
C-trap dissociation (HCD) fragmentation (Olsen et al., 2007). Raw data filesCell Reports 4, 842–851, August 29, 2013 ª2013 The Authors 849
were processed using MaxQuant software (development v1.2.7.1; http://
www.maxquant.org/) as described previously (Cox et al., 2011). Parent ion
(MS) and fragment (MS2) spectra were searched against the Saccharomyces
Genome Database genome release r63, January 5, 2010, and E. coli,
human, and mouse data were searched against the UniProt species-
specific fasta files from the April 2012 release. The search was performed
using the integrated Andromeda search engine and both forward and
reversed (decoy) versions of the databases (Cox et al., 2011). Peptides were
identified by a target-decoy based strategy (Elias and Gygi, 2007),
allowing a maximum false discovery rate of <1%. We applied further strict
criteria on MS2 identification by requiring a PEP score < 0.01 and an
Andromeda peptide score > 45, resulting in estimated FDRs that were below
1% (Table S10). The confidence of any given peptide identification is
indicated by the PEP and Andromeda scores; high-confidence identifications
have lower PEP scores and higher Andromeda scores (for more details, see
Cox and Mann, 2008; Cox et al., 2011). Mass recalibration was performed
using high confidence identifications based on an initial ‘‘first search’’ using
a 20 parts per million (ppm) mass tolerance for parent ion masses and 20
ppm (HCD) for fragment ions. Spectra were subsequently searched with a
mass tolerance of 6 ppm for parent ions and 20 ppm (HCD) for fragment
ions, with strict trypsin specificity, and allowing up to 2 missed cleavage sites.
Cysteine carbamidomethylation was searched as a fixed modification,
whereas N-acetyl protein and oxidized methionine were searched as variable
modifications. Succinyllysine adds a 100.0160 mass shift that is readily distin-
guishable from acetylation (42.0106), malonylation (86.0004), propionylation
(56.0262), and crotonylation (69.0340), since the orbitrap analyzer used for
fragment scans has a ppm-range mass accuracy. Methylmalonylation has
an identical mass as succinylation and is not distinguishable in the MS, but
antibody enrichment should specifically select for succinylated lysine as we
were unable to detect substantial enrichment of other acylations (data not
shown) and we observed altered succinylation levels upon manipulation of
the enzymes regulating succinyl-CoA formation in yeast, suggesting that we
primarily detect succinylation by this method. MS raw data are available
upon request.
Data analysis
Gene Ontology (GO) and KEGG pathway association and enrichment
analysis was performed using the Database for Annotation, Visualization and
Integrated Discovery (DAVID) v6.7 (Huang da et al., 2009). Filled logo motifs
were generated using iceLogo (Colaert et al., 2009). Relative protein abun-
dances (intensity-based absolute quantification [iBAQ]) were determined
using MaxQuant. iBAQ values are calculated by taking the summed peptide
intensities for a given protein and dividing by the number of theoretically
observable tryptic peptides (Schwanha¨usser et al., 2011). Overlap between
succinylation sites and previously published acetylation sites was determined
by comparing 13-amino-acid sequence windows (modification site ±
six amino acids). Secondary structure biases were determined using the
secondary structure assignments found in the UniProt database (http://
www.uniprot.org/), when present.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
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